dihydroxyphenylalanine has been researched along with carbidopa in 139 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 85 (61.15) | 18.7374 |
1990's | 30 (21.58) | 18.2507 |
2000's | 9 (6.47) | 29.6817 |
2010's | 15 (10.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Borison, RL; Giardina, WJ; Mosnaim, AD; Pedemonte, WA; Sabelli, HC; Vazquez, AJ | 1 |
Losey, EG; VonVoigtlander, PF | 1 |
Ogawa, M; Tohgi, H | 1 |
Watkins, CJ; Wiggins, JF; Wurtman, RJ | 1 |
Grimm, W; Schönberger, W; Ziegler, R | 2 |
Estey, E; Goldstein, M; Gopinathan, G; Lieberman, A; Ohashi, T; Sauter, A | 1 |
McDowell, FH; Miller, ST; Papavasiliou, PS; Rosal, V; Wang, YY | 1 |
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
Beerling-van der Molen, HD; Korf, J; Paans, AM; Reiffers, S; Ten Hoeve, W; Vaalburg, W; Woldring, MG; Wynberg, H | 1 |
Beerling-van der Molen, HD; Korf, J; Lakke, JP; Paans, AM; Reiffers, S; Vaalburg, W; Woldring, MG | 1 |
Jenner, PG; Jones, MK; Ramsay, ID | 1 |
Barkhatova, VP; Markova, ED | 1 |
Borge, GF; Buchsbaum, M; Maas, JW; Redmond, DE | 1 |
Watkins, CJ; Wurtman, RJ | 1 |
Mizuno, Y; Obayashi, T; Ueki, A; Yoshida, M | 1 |
Cohen, HP; Jacobson, RL; Martin, WE; Tolosa, ES | 1 |
Osborne, MW; Wenger, JJ | 1 |
Fellman, JH; Fujita, TS; Heriza, EL; Roth, ES | 1 |
Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA | 1 |
Inglis, GC; Kenyon, CJ | 1 |
Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA; Wyatt, RJ | 1 |
Barrio, JR; Grafton, SC; Hawk, TC; Hoffman, JM; Huang, SC; Luxen, A; Mahoney, DK; Mazziotta, JC; Melega, WP; Phelps, ME | 1 |
Aigner, TG; Brücke, T; Cohen, RM; Doudet, DJ; McLellan, CA | 1 |
Adam, MJ; Chan, GL; Hewitt, KA; Pate, BD; Ruth, TJ; Schofield, P | 1 |
Adams, HR; Aigner, TG; Cohen, RM; Doudet, DJ; Finn, RT; McLellan, CA; Miyake, H; Wyatt, R | 1 |
Barrio, JR; Grafton, ST; Huang, SC; Melega, WP; Phelps, ME; Satyamurthy, N | 1 |
Barrio, JR; Luxen, A; Melega, WP; Nissenson, CH; Perlmutter, MM; Phelps, ME | 1 |
Barrio, JR; Hoffman, JM; Luxen, A; Melega, WP; Nissenson, CH; Phelps, ME | 1 |
Cohen, G; Evans, JM | 1 |
Bazan, E; de Yebenes, JG; Mena, MA; Muradas, V; Reiriz, J | 1 |
Borisenko, SA; Burov, IuV; Kiianmaa, K; Lehtosalo, J; Mannisto, P | 1 |
Cedarbaum, JM; Dhar, AK; Kutt, H; McDowell, FH; Watkins, S | 1 |
Epstein, FH; Gunn, S; Landsberg, L; Rosa, RM; Williams, M; Young, JB | 1 |
Boyes, BE; Cumming, P; Martin, WR; McGeer, EG | 1 |
Cohen, G; Orosz, D | 1 |
Da Prada, M; Haefely, WE; Kettler, R; Schaffner, R; Zürcher, G | 1 |
Adam, MJ; Cumming, P; Grierson, J; Häusser, M; Martin, WR; McGeer, EG; Ruth, TJ | 1 |
Jeffrey, RF; Lee, MR; MacDonald, TM; Marwick, K | 1 |
Cannon-Spoor, E; Chuang, LW; Costa, E; Freed, WJ; Karoum, F; Wyatt, RJ | 1 |
Borisenko, SA | 1 |
Amanova, ZN; Badalian, LO; Grinio, ZN; Sadovskaia, IuE; Temin, PA | 1 |
Chase, TN; Fermaglich, J | 1 |
Chase, TN; Woods, AC | 1 |
Atkins, FL; Beaven, MA; Keiser, HR | 1 |
Bolme, P; Fuxe, K | 1 |
Clark, CM; Lotti, VJ; Stone, CA; Torchiana, ML | 1 |
Ahlenius, S | 1 |
Frigyesi, TL; Schwartz, R; Yahr, MD | 1 |
Strömberg, U; Waldeck, B | 1 |
Minsker, DH; Stokes, AL | 1 |
Sethy, VH; Van Woert, MH | 2 |
Henning, M; Pernevi, P; Trolin, G | 1 |
Fermaglich, J | 1 |
Porter, CC; Stone, CA; Torchiana, ML | 1 |
Malmnäs, CO | 1 |
Atkinson, JM; Schmitt, H; Sinha, JN | 1 |
Mones, RJ | 2 |
Olanow, CW; Schwartz, AM; Spencer, A | 1 |
Andrews, CJ; Somerville, B | 1 |
Friedman, E; Gershon, S | 1 |
Barry, PE; Marsden, CD; Parkes, JD; Zilkha, KJ | 1 |
Chase, TN; Donnelly, EF | 1 |
Klawans, HL; Ringel, SP | 1 |
Fenard, S; Schmitt, H | 1 |
Dinsmore, SR; Mrochek, JE; Ohrt, DW | 1 |
Calne, DB; Reid, JL | 1 |
Cotzias, GC; Lawrence, WH; Papavasiliou, PS | 1 |
Brody, JA; Chase, TN; Holden, EM | 2 |
Dick, P; Eisenring, JJ; Tissot, R; Yanniotis, G | 1 |
Mars, H | 2 |
Cardon, PV; Judy, WV; Watanabe, AM | 1 |
Calne, DB; Johnson, RD; Reid, JL; Ruthven, CR; Sandler, M | 1 |
Duvoisin, RC; Marsden, CD | 1 |
Fahn, S; Prasad, AL | 1 |
Clark, C; Lotti, VJ | 1 |
Diamond, SG; Markham, C; Treciokas, LJ | 1 |
Fuxe, K; Hökfelt, T; Johansson, O; Ljungdahl, A | 1 |
Fahn, S | 1 |
Miller, EM; Wiener, L | 1 |
Cotzias, GC; Dahl, LK; Düby, SE | 1 |
Gunder, M; Miller, S; Stewart, RM | 1 |
Beck, B; Brandt, NJ; Christensen, E; Niederwieser, A; Pedersen, PS | 1 |
Hiramatsu, M | 1 |
Anton, AH; Crumrine, RS; Izant, RJ; Stern, RC | 1 |
Baines, AD; Drangova, R | 1 |
Kawamura, M; Nakane, H; Saruta, T; Suzuki, H; Takeshita, E; Yoshizawa, M | 1 |
Beers, MF; Hurtig, H; Melvin, G; Scarpa, A; Stern, M | 1 |
Bonora, M; Gautier, H | 1 |
Anderson, GM; Chouinard, G; Gauthier, S; Purdy, WC; Young, SN | 1 |
Vartanian, KZ | 1 |
Lang, AE | 1 |
Ase, A; Cumming, P; Diksic, M; Gjedde, A; Harrison, J; Jolly, D; Kuwabara, H; Laliberté, C | 1 |
Eriksson, T; Holmgren, B | 1 |
Chan, GL; Dobko, T; Doudet, DJ; Hewitt, KA; Pate, BD; Ruth, TJ; Schofield, P | 1 |
Lang, A; Männistö, PT; Rauhala, P; Vasar, E | 1 |
Brooks, DJ; Burn, DJ; Lammertsma, AA; Luthra, S; Morrish, PK; Osman, S; Sawle, GV; Snow, BJ | 1 |
Dethy, S; Goldman, S; Luxen, A; Monclus, M; Pauwels, T | 1 |
Chrapusta, SJ; Egan, MF; Karoum, F; Wyatt, RJ | 1 |
Fukumura, T; Ichiya, Y; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M | 1 |
Cumming, P; Gjedde, A; Kuwabara, H; Léger, GC | 1 |
Bennett, JP; Schuh, LA | 1 |
Kaakkola, S; Wurtman, RJ | 1 |
Dubinsky, R; Hubble, JP; Koller, WC; Lyons, K; McGuire, D; Pahwa, R | 1 |
Ishii, S; Ishiwata, K; Nozaki, T; Senda, M; Shinoda, M | 1 |
Ashworth, S; Bloomfield, PM; Fricker, RA; Hume, SP; Jones, T; Lammertsma, AA; Myers, R; Rajeswaran, S; Torres, EM; Watson, I | 1 |
da Cruz Vieira, I; Fatibello-Filho, O | 1 |
Ase, A; Cumming, P; Gjedde, A; Kuwabara, H; Laliberté, C | 1 |
Brown, WD; DeJesus, OT; Holden, JE; Nickles, RJ; Oakes, TR; Roberts, AD; Taylor, MD | 1 |
Cumming, P; Danielsen, EH; Gee, AD; Gjedde, A; Hansen, SB; Hermansen, F; Smith, DF; Venkatachalam, TK | 1 |
Brousolle, E; Dentresangle, C; Froment, JC; Guerin, J; Lavenne, F; Le Bars, D; Pierre, C; Pollak, P; Veyre, L | 1 |
Blaschke, G; Chankvetadze, B; Saraç, S | 1 |
Dolezalová, M; Fanali, S | 1 |
Brus, R; Kostrzewa, JP; Kostrzewa, RM | 1 |
Ha, PT; Hauta-Aho, T; Hoogmartens, J; Roets, E; Van Schepdael, A | 1 |
Konno, R; Wang, YX; Wu, M; Zhou, XJ | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Hadi, M; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
Kauhanen, S; Nuutila, P; Seppänen, M | 1 |
Cichoń, T; Frackowiak-Wojtasek, B; Gasowska-Bajger, B; Koj, S; Smolarczyk, R; Szala, S; Wojtasek, H | 1 |
Muhlack, S; Müller, T | 1 |
Abbs, JH; Bendlin, BB; Brooks, BR; Brown, WD; Chung, MK; Dejesus, OT; Dogan, S; Gallagher, CL; Holden, JE; Johnson, SC; Konopacki, RA; Nickles, RJ; Oakes, TR; Pyzalski, RW; Xu, G | 1 |
Chiti, A; D'Ambrosio, D; Fanti, S; Lopci, E; Marengo, M; Nanni, C; Pession, A | 1 |
Fukui, M; Kang, KS; Wen, Y; Yamabe, N; Zhu, BT | 1 |
Addeo, P; Averous, G; Bachellier, P; Imperiale, A; Namer, IJ | 1 |
Chondrogiannis, S; Marzola, MC; Rubello, D | 1 |
Santhanam, P; Taïeb, D | 1 |
Bachellier, P; Castinetti, F; Guillet, B; Imperiale, A; Kessler, L; Moreau, F; Mundler, O; Namer, IJ; Sebag, F; Taïeb, D; Vix, M | 1 |
Bachellier, P; Bahougne, T; Goichot, B; Imperiale, A; Namer, IJ; Taïeb, D | 1 |
Cardoso, MA; de Carvalho, KA; de Francisco, TM; de Oliveira Vilhena, R; Gasparetto, JC; Guimarães de Francisco, TM; Martins, CA; Pontarolo, R; Ribeiro, RP | 1 |
Harada, N; Kakiuchi, T; Kanazawa, M; Muramatsu, S; Ohba, H; Tsukada, H | 1 |
Bishnoi, P; Charde, SY; Raut, PP | 1 |
Boisson, F; Brasse, D; Detour, J; Imperiale, A; Kessler, L; Kreutter, G; Lavaux, T; Marchand, P; Namer, IJ; Pierre, A | 1 |
Boellaard, R; de Heide, LJ; de Vries, EG; Glaudemans, AW; Noordzij, W; Slart, RH; van Beek, AP; van der Horst-Schrivers, AN; van Ginkel, B | 1 |
Berger, E; El-Rabadi, K; Hacker, M; Haug, A; Karanikas, G; Nakuz, TS; Wadsak, W | 1 |
4 review(s) available for dihydroxyphenylalanine and carbidopa
Article | Year |
---|---|
Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle.
Topics: 5-Hydroxytryptophan; Animals; Brain; Carbidopa; Deamination; Dihydroxyphenylalanine; Evoked Potentials; Humans; Mental Disorders; Methyldopa; Neural Inhibition; Neurons; Neurotransmitter Agents; Phenethylamines; Probenecid; Rabbits; Rats; Receptors, Drug; Synapses; Synaptic Transmission; Visual Perception | 1976 |
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed | 1995 |
¹⁸F-DOPA PET/computed tomography imaging.
Topics: Abdomen; Carbidopa; Congenital Hyperinsulinism; Corpus Striatum; Digestive System; Dihydroxyphenylalanine; Fluorine Radioisotopes; Head; Humans; Neck; Neuroendocrine Cells; Positron-Emission Tomography; Radiopharmaceuticals; Thorax; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
10 trial(s) available for dihydroxyphenylalanine and carbidopa
Article | Year |
---|---|
[Effect of MK-486 alone on Parkinsonism; studies on the clinical symptoms and catecholamine concentrations in the blood, urine and cerebrospinal fluid].
Topics: Aged; Carbidopa; Catecholamines; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Female; Homovanillic Acid; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease | 1977 |
Methyldopa or methyldopahydrazine as levodopa synergists.
Topics: Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Humans; Hydrazines; Methyldopa; Parkinson Disease | 1973 |
Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrazines; Methyldopa; Middle Aged; Parkinson Disease | 1974 |
A double-blind controlled study of MK-486 in Parkinson's disease.
Topics: Aged; Anorexia Nervosa; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Nausea; Parkinson Disease; Placebos | 1973 |
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos | 1974 |
Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
Topics: Adult; Aged; Carbidopa; Dihydroxyphenylalanine; Educational Status; Female; Humans; Intelligence; Intelligence Tests; Male; Memory; Middle Aged; Parkinson Disease; Placebos; Psychological Tests | 1973 |
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease.
Topics: Aged; Brain; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dihydroxyphenylalanine; Drug Synergism; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Nitriles; Occipital Lobe; Parkinson Disease; Tomography, Emission-Computed | 1994 |
Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.
Topics: Aged; Carbidopa; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Dihydroxyphenylalanine; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1996 |
The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Image Enhancement; Male; Metabolic Clearance Rate; Middle Aged; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Feasibility of carbidopa premedication in pediatric patients: a pilot study.
Topics: Carbidopa; Child; Child, Preschool; Dihydroxyphenylalanine; Drug Interactions; Female; Fluorine Radioisotopes; Humans; Male; Neuroblastoma; Pilot Projects; Premedication; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
125 other study(ies) available for dihydroxyphenylalanine and carbidopa
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
On the use of selective neurotoxic amine analogs to measure the blockade of norepinephrine and 5-hydroxytryptamine uptake systems by antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Carbidopa; Diazepam; Dihydroxyphenylalanine; Drug Interactions; Imipramine; Male; Methamphetamine; Mice; Neurons; Norepinephrine; Pargyline; Serotonin | 1976 |
Carbidopa elevates hypothalamic dopa and serum prolactin in rats.
Topics: Animals; Brain Chemistry; Carbidopa; Dihydroxyphenylalanine; Hypothalamus; Male; Median Eminence; Postmortem Changes; Prolactin; Pyridoxine; Rats; Time Factors | 1979 |
[Improvement of growth-hormone stimulation with l-dopa/l-carbidopa by simultaneous administration of propranolol (author's transl)].
Topics: Carbidopa; Child; Dihydroxyphenylalanine; Drug Therapy, Combination; Dwarfism; Growth Hormone; Humans; Propranolol | 1979 |
Comparative effectiveness of two extracerebral DOPA decarboxylase inhibitors in Parkinson disease.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease | 1978 |
Plasma DOPA and growth hormone in parkinsonism: oscillations in symptoms.
Topics: Aged; Carbidopa; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
The effect of nacom (L-dopa and L-carbidopa) on growth hormone secretion in 75 patients with short stature.
Topics: Adolescent; Arginine; Carbidopa; Child; Child, Preschool; Dihydroxyphenylalanine; Dwarfism; Growth Hormone; Humans; Hydrazines; Secretory Rate | 1977 |
Rapid synthesis and purification of carbon-11 labelled DOPA: a potential agent for brain studies.
Topics: Animals; Brain; Carbidopa; Carbon Radioisotopes; Dihydroxyphenylalanine; Male; Radionuclide Imaging; Rats | 1977 |
Rapid decarboxylation of carbon-11 labelled DL-DOPA in the brain: a potential approach for external detection of nervous structures.
Topics: Animals; Brain; Brain Stem; Carbidopa; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dihydroxyphenylalanine; Hydroxydopamines; Male; Occipital Lobe; Premedication; Radionuclide Imaging; Rats; Receptors, Cholinergic; Receptors, Dopamine | 1978 |
The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
Topics: Adult; Aged; Breast Neoplasms; Carbidopa; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Hydrazines; Levodopa; Middle Aged; Prolactin; Thyroxine; Time Factors | 1978 |
[Pathogenesis and treatment of torsion dystonia].
Topics: Carbidopa; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Epinephrine; Homovanillic Acid; Humans; Hydrazines; Jews; Levodopa; Norepinephrine; Vanilmandelic Acid | 1978 |
Evoked potential studies of brain catecholamine alterations in monkeys.
Topics: Animals; Brain; Brain Chemistry; Carbidopa; Catecholamines; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Droxidopa; Electrophysiology; Evoked Potentials; Female; Haplorhini; Macaca; Male; Methyltyrosines; Norepinephrine; Photic Stimulation | 1975 |
Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
Topics: Adrenergic Fibers; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Dopamine; Heart; Hydrazines; Male; Norepinephrine; Peripheral Nerves; Rats; Tyrosine | 1977 |
[Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].
Topics: Adult; Aged; Benserazide; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease | 1976 |
Patterns of clinical response and plasma dopa levels in Parkinson's disease.
Topics: Adult; Aged; Brain; Carbidopa; Dihydroxyphenylalanine; Disability Evaluation; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1975 |
Effects of L-dopa on myocardial contractile force: a reappraisal.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Carbidopa; Cardiac Output; Dihydroxyphenylalanine; Dogs; Female; Heart Rate; Male; Myocardial Contraction; Time Factors | 1975 |
Altered pattern of dopa metabolism.
Topics: Animals; Carbidopa; Cytosol; Dihydroxyphenylalanine; Hydrazines; Kidney; Kinetics; Liver; Mitochondria; Rats; Transaminases | 1976 |
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed | 1992 |
Effects of long-term infusions of dopa and carbidopa on renin and steroid secretion in the rat.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Aldosterone; Animals; Carbidopa; Corticosterone; Desoxycorticosterone; Dihydroxyphenylalanine; Dopamine; Kidney; Male; Rats; Rats, Sprague-Dawley; Renin | 1992 |
Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-dopa uptake in brain.
Topics: Animals; Brain; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Macaca mulatta; MPTP Poisoning; Phenylalanine; Time Factors; Tomography, Emission-Computed | 1992 |
The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Topics: Adult; Animals; Carbidopa; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Injections, Intravenous; Macaca nemestrina; Male; Tomography, Emission-Computed | 1992 |
New rapid analysis method demonstrates differences in 6-[18F] fluoro-L-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys.
Topics: Animals; Carbidopa; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Functional Laterality; Kinetics; Macaca mulatta; MPTP Poisoning; Reference Values; Synapses; Time Factors | 1991 |
Routine determination of [18F]-L-6-fluorodopa and its metabolites in blood plasma is essential for accurate positron emission tomography studies.
Topics: Adsorption; Age Factors; Aluminum Oxide; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Humans; Tomography, Emission-Computed; Tyrosine | 1992 |
Postinjection L-phenylalanine increases basal ganglia contrast in PET scans of 6-18F-DOPA.
Topics: Animals; Basal Ganglia; Carbidopa; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Macaca mulatta; Male; Phenylalanine; Time Factors; Tomography, Emission-Computed | 1991 |
L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
Topics: Adult; Animals; Blood Chemical Analysis; Brain; Carbidopa; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Macaca nemestrina; Male; Tissue Distribution; Tomography, Emission-Computed | 1991 |
Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
Topics: Animals; Brain; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Injections, Intravenous; Kinetics; Levodopa; Male; Rats; Rats, Inbred Strains; Tritium | 1990 |
The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans.
Topics: Adult; Animals; Carbidopa; Cerebellum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Macaca fascicularis; Male; Rats; Rats, Inbred Strains | 1990 |
Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA).
Topics: Animals; Brain; Carbidopa; Cerebral Cortex; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Frontal Lobe; Hydroxydopamines; Male; Mice; Norepinephrine; Oxidopamine; Pargyline; Reserpine; Synaptic Vesicles | 1989 |
Pharmacokinetics of L-dopa in patients with Parkinson's disease.
Topics: Biotransformation; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Kinetics; Levodopa; Methyldopa; Parkinson Disease; Receptors, Dopamine; Receptors, Dopamine D2; Tiapamil Hydrochloride | 1987 |
[Effect of a single ethanol administration on the permeability of the hemato-encephalic barrier for 14C-tyrosine, 14C-DOPA and horseradish peroxidase].
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Carbidopa; Carbon Radioisotopes; Cell Membrane Permeability; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Ethanol; Horseradish Peroxidase; Male; Peroxidases; Rats; Rats, Inbred Strains; Tyrosine | 1986 |
Effect of supplemental carbidopa on bioavailability of L-dopa.
Topics: Aged; Biological Availability; Carbidopa; Dihydroxyphenylalanine; Drug Administration Schedule; Humans; Levodopa; Parkinson Disease | 1986 |
Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.
Topics: Adult; Aldosterone; Analysis of Variance; Body Water; Carbidopa; Creatinine; Decarboxylation; Dietary Proteins; Dihydroxyphenylalanine; Dopamine; Humans; Kidney; Male; Norepinephrine; Potassium; Sodium | 1986 |
Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Age Factors; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dystonia; Humans; Kinetics; Metabolic Clearance Rate; Parkinson Disease; Pyridines; Tomography, Emission-Computed | 1986 |
Decarboxylation of DL-2,4-dihydroxyphenylalanine (2,4-DOPA) to 2,4-dihydroxyphenylethylamine in mouse striatal slices.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Chromatography, High Pressure Liquid; Corpus Striatum; Decarboxylation; Dihydroxyphenylalanine; In Vitro Techniques; Male; Mice; Phenethylamines | 1987 |
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Topics: Administration, Oral; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Brain; Carbidopa; Delayed-Action Preparations; Dihydroxyphenylalanine; Dogs; Dopa Decarboxylase; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrazines; Kidney; Levodopa; Liver; Male; Mice; Rats; Time Factors; Tyrosine | 1987 |
Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.
Topics: Animals; Carbidopa; Corpus Striatum; Decarboxylation; Dihydroxyphenylalanine; Fluorine Radioisotopes; In Vitro Techniques; Kinetics; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Tissue Distribution | 1988 |
The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Dopamine; Humans; Indomethacin; Kallikreins; Kidney; Male; Renin; Sodium | 1988 |
D-dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Carbidopa; Cerebral Ventricles; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Levodopa; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior; Structure-Activity Relationship | 1988 |
[Effect of carbidopa and dimethyl sulfoxide on the permeability of the hemato-encephalic barrier for 14C-tyrosine and 14C-DOPA in rats].
Topics: Animals; Blood-Brain Barrier; Brain; Carbidopa; Carbon Radioisotopes; Cell Membrane Permeability; Dihydroxyphenylalanine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred Strains; Tyrosine | 1988 |
[Effect of the test with the drug Nakom on the dynamics of excretion of catecholamines and DOPA in children with Duchenne's progressive muscular dystrophy].
Topics: Adolescent; Carbidopa; Catecholamines; Child; Child, Preschool; Circadian Rhythm; Dihydroxyphenylalanine; Drug Combinations; Humans; Levodopa; Muscular Dystrophies | 1985 |
M.I.F.: effect on levodopa dyskinesias in man.
Topics: Antiparkinson Agents; Carbidopa; Carboxy-Lyases; Decarboxylation; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Humans; Melanocyte-Stimulating Hormones; Methylation; Movement Disorders; Parkinson Disease | 1973 |
Dopa decarboxylase in medullary carcinoma of the thyroid.
Topics: Adrenal Gland Neoplasms; Amine Oxidase (Copper-Containing); Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Carcinoma; Cresols; Dihydroxyphenylalanine; Dopa Decarboxylase; Histamine; Histidine; Humans; Hydrazines; Hydroxylamines; Methyldopa; Methylhistidines; Norepinephrine; Pheochromocytoma; Serotonin; Thyroid Gland; Thyroid Neoplasms; Tryptophan; Tyrosine; Tyrosine 3-Monooxygenase | 1973 |
Pharmacological studies on a possible role of central noradrenaline neurons in respiratory control.
Topics: Amines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benzyl Compounds; Carbidopa; Clonidine; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Guanidines; Male; Neurons; Norepinephrine; Rats; Respiration; Time Factors | 1973 |
Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
Topics: Adrenergic alpha-Antagonists; Amino Acids; Animals; Antihypertensive Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benzoates; Blood Pressure; Carbidopa; Cats; Cerebral Ventricles; Dihydroxyphenylalanine; Disulfides; Dopamine beta-Hydroxylase; Female; Imidazoles; Male; Methyldopa; Perfusion; Phentolamine; Pyrimidines; Spiro Compounds; Sulfhydryl Compounds; Time Factors | 1973 |
Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
Topics: Animals; Brain; Carbidopa; Dihydroxyphenylalanine; Disulfides; Dopamine; Dopamine beta-Hydroxylase; Female; Imidazoles; Locomotion; Methyltyrosines; Mice; Norepinephrine; Reserpine; Synaptic Transmission; Tritium; Tyrosine 3-Monooxygenase | 1974 |
Electrophysiological analysis of the effects of L-dopa on the reciprocal corticothalamic projections in the squirrel monkey. I. Iatrogenic coma and disinhibition of medial thalamic neurons.
Topics: Animals; Carbidopa; Caudate Nucleus; Coma; Dihydroxyphenylalanine; Disease Models, Animal; Electric Stimulation; Electroencephalography; Evoked Potentials; Haplorhini; Motor Cortex; Neural Inhibition; Neural Pathways; Thalamic Nuclei; Thalamus | 1974 |
Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Caffeine; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Hydroxyindoleacetic Acid; Locomotion; Mice; Motor Activity; Norepinephrine; Receptors, Adrenergic; Serotonin; Synaptic Transmission; Tritium; Tyrosine | 1973 |
Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Carbidopa; Dihydroxyphenylalanine; Dogs; Female; Heart Rate; Hydrazines; Male; Tyrosine | 1974 |
Regulation of striatal acetylcholine concentration by dopamine receptors.
Topics: Acetylcholine; Animals; Apomorphine; Brain Chemistry; Carbidopa; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Pimozide; Rats; Receptors, Adrenergic | 1974 |
Spinal noradrenaline mechanisms and blood pressure: effect of local treatment with 6-hydroxydopamine in the rat.
Topics: Animals; Blood Pressure; Carbidopa; Clonidine; Depression, Chemical; Dihydroxyphenylalanine; Heart Rate; Hydroxydopamines; Male; Norepinephrine; Rats; Reflex; Spinal Cord; Stimulation, Chemical; Time Factors | 1974 |
Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
Topics: Aged; Carbidopa; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease | 1974 |
(S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Brain; Brain Chemistry; Carbidopa; Catechols; Decarboxylation; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dose-Response Relationship, Drug; Female; Kidney; Male; Mice; Myocardium; Norepinephrine; Rats; Serine; Stereoisomerism; Structure-Activity Relationship; Tyramine | 1972 |
Monoamine precursors and copulatory behavior in the male rat.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Carbidopa; Carboxy-Lyases; Castration; Copulation; Depression, Chemical; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Ejaculation; Female; Hydrazines; Injections, Intraperitoneal; Male; Monoamine Oxidase Inhibitors; Motor Activity; Nialamide; Pargyline; Rats; Sexual Behavior, Animal; Stimulation, Chemical; Testosterone; Time Factors | 1973 |
Effects of clonidine and L-dopa on spontaneous and evoked splanchnic nerve discharges.
Topics: Animals; Blood Pressure; Carbidopa; Cats; Clonidine; Dihydroxyphenylalanine; Electric Stimulation; Evoked Potentials; Female; Heart Rate; Hypothalamus; Laminectomy; Male; Medulla Oblongata; Norepinephrine; Pressoreceptors; Receptors, Adrenergic; Sciatic Nerve; Spinal Cord; Splanchnic Nerves; Stereotaxic Techniques; Sympatholytics; Yohimbine | 1973 |
L-DOPA: centrally mediated emission of seminal fluid in male rats.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Atropine; Benserazide; Carbidopa; Cyproheptadine; Dihydroxyphenylalanine; Dopamine; Ejaculation; Haloperidol; Hydrazines; Hypophysectomy; Lysergic Acid Diethylamide; Male; Melatonin; Methysergide; Norepinephrine; Phentolamine; Propranolol; Rats; Semen; Serotonin | 1972 |
Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease | 1973 |
L-Dopa, B 6 , and alpha-methyldopa hydrazine.
Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Pyridoxine | 1973 |
An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy.
Topics: Aged; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Male; Muscle Rigidity; Muscles; Neurologic Examination; Parkinson Disease; Tremor | 1973 |
Localization of the site of the central sympatho-inhibitory action of 1-Dopa in dogs and cats.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Brain Stem; Carbidopa; Cats; Clonidine; Decerebrate State; Dihydroxyphenylalanine; Dogs; Female; Heart Rate; Hydrazines; Injections, Intra-Arterial; Male; Splanchnic Nerves; Sympathetic Nervous System; Time Factors; Vertebral Artery | 1973 |
Monitoring phenylalanine-tyrosine metabolism by high-resolution liquid chromatography of urine.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Autistic Disorder; Carbidopa; Catechols; Child; Chromatography, Gas; Chromatography, Ion Exchange; Dihydroxyphenylalanine; Hippurates; Homovanillic Acid; Humans; Hyperkinesis; Intellectual Disability; Lactates; Mandelic Acids; Mass Spectrometry; Methods; Nervous System Diseases; Parkinson Disease; Phenylacetates; Phenylalanine; Spectrophotometry, Ultraviolet; Tyrosine | 1973 |
Actions of levodopa on the blood pressure of conscious rabbits.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Carbidopa; Dihydroxyphenylalanine; Iproniazid; Male; Monoamine Oxidase Inhibitors; Rabbits; Time Factors | 1973 |
Levodopa and dopamine in cerebrospinal fluid.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease; Pyridoxine; Spinal Puncture; Trihexyphenidyl | 1973 |
Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Carbidopa; Dementia; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1973 |
[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].
Topics: Adult; Aged; Anxiety; Carbidopa; Carboxy-Lyases; Depression; Desipramine; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged | 1973 |
Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
Topics: Brain; Carbidopa; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Homovanillic Acid; Humans; Hydrazines; Parkinson Disease; Pyridoxine | 1973 |
Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Autonomic Fibers, Postganglionic; Autonomic Fibers, Preganglionic; Blood Pressure; Carbidopa; Cats; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Heart; Heart Rate; In Vitro Techniques; Kidney; Neurons; Pressoreceptors; Splanchnic Nerves; Sympathetic Nervous System; Time Factors | 1974 |
Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Homovanillic Acid; Humans; Hydrazines; Phenylacetates; Transaminases | 1974 |
Reversal of reserpine-induced bradykinesia by alpha-methyldopa--new light on its modus operandi.
Topics: Animals; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Disease Models, Animal; Disulfiram; Dose-Response Relationship, Drug; Drug Synergism; Methyldopa; Mice; Movement Disorders; Parkinson Disease; Phenoxybenzamine; Pimozide; Reserpine | 1974 |
3-O-methyl metabolites of catecholamines: automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopa.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Autoanalysis; Blood-Brain Barrier; Brain Chemistry; Carbidopa; Chromatography, Ion Exchange; Dihydroxyphenylalanine; Dopamine; Evaluation Studies as Topic; Homovanillic Acid; Humans; Methods; Methyldopa; Microchemistry; Phenylacetates; Spectrometry, Fluorescence; Time Factors | 1974 |
Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.
Topics: Carbidopa; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Drug Interactions; Drug Synergism; Homovanillic Acid; Humans; Hydrazines; Parkinson Disease; Pyridoxine | 1974 |
Carbidopa attenuation of L-DOPA emesis in dogs: evidence for a cerebral site of action outside the blood-brain barrier.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Binding Sites; Blood-Brain Barrier; Brain; Carbidopa; Cerebral Ventricles; Dihydroxyphenylalanine; Dogs; Dopamine; Emetics; Hydrazines; Injections; Injections, Intravenous | 1974 |
Carbidopa in Parkinson disease and in nausea and vomiting of levodopa.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting | 1974 |
Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
Topics: Acetylcholine; Amphetamine; Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Brain Stem; Carbidopa; Cerebral Cortex; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Dibenzazepines; Dihydroxyphenylalanine; Dioxoles; Dopamine; Drug Synergism; Haloperidol; Hippocampus; Hypothalamus; Male; Pimozide; Piperazines; Pyrimidines; Rats; Receptors, Drug; Thalamus; Time Factors | 1974 |
Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
Topics: Adult; Aged; Carbidopa; Dementia; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Pacific Islands; Parkinson Disease | 1974 |
Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia.
Topics: Animals; Carbidopa; Dihydroxyphenylalanine; Disulfides; Dopamine; Dopamine beta-Hydroxylase; Humans; Imidazoles; Limbic System; Male; Microscopy, Fluorescence; Rats; Receptors, Drug; Reserpine; Schizophrenia | 1974 |
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Injections, Intramuscular; Male; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Pyridoxine | 1974 |
Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia Diseases; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease | 1974 |
Coupling of hypotensive and anit-Parkinson effects with two dopaminergic drugs.
Topics: Apomorphine; Blood Pressure; Brain; Carbidopa; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Synergism; Humans; Hydrazines; Hypotension; Parkinson Disease; Time Factors | 1971 |
Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Topics: Adult; Aged; Carbidopa; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms | 1983 |
Diagnostic and therapeutic aspects of dihydrobiopterin deficiency.
Topics: 5-Hydroxytryptophan; Biopterins; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Humans; Infant; Male; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines | 1983 |
Brain 5-hydroxytryptamine level, metabolism, and binding in E1 mice.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Carbidopa; Dihydroxyphenylalanine; Mice; Mice, Inbred Strains; Monoamine Oxidase; Physical Stimulation; Serotonin | 1983 |
Inhibition of catecholamine biosynthesis by carbidopa and metyrosine in neuroblastoma.
Topics: alpha-Methyltyrosine; Carbidopa; Catecholamines; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Female; Homovanillic Acid; Humans; Infant; Male; Methyltyrosines; Neuroblastoma; Norepinephrine; Vanilmandelic Acid | 1983 |
Dopamine production by the isolated perfused rat kidney.
Topics: Animals; Carbidopa; Catecholamines; Denervation; Dihydroxyphenylalanine; Dopamine; In Vitro Techniques; Kidney; Male; Neurons; Rats; Rats, Inbred Strains; Time Factors; Tyrosine | 1984 |
Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Dopamine; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Male; Perfusion; Rats; Rats, Inbred Strains | 1984 |
Simultaneous determination of L-dopa and 3-O-methyldopa in human serum by high-performance liquid chromatography.
Topics: Adult; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Epinephrine; Humans; Levodopa; Male; Methyltyrosines; Norepinephrine; Parkinson Disease; Tyrosine | 1984 |
Possible alterations in brain monoamine metabolism during hypoxia-induced tachypnea in cats.
Topics: Aminophylline; Animals; Biogenic Amines; Brain; Caffeine; Carbidopa; Cats; Dihydroxyphenylalanine; Doxapram; Hypercapnia; Hypoxia; Respiration Disorders | 1980 |
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; Hydrazines; Middle Aged; Parkinson Disease; Schizophrenia; Tryptophan | 1982 |
[Biochemical evaluation of the effectiveness of antiparkinson preparations containing L-DOPA].
Topics: Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Combinations; Epinephrine; Humans; Levodopa; Norepinephrine; Parkinson Disease | 1981 |
Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
Topics: Animals; Blood-Brain Barrier; Carbidopa; Dihydroxyphenylalanine; Fluorine Radioisotopes; Male; Methylation; Rats; Rats, Wistar; Tritium | 1995 |
Rapid degradation of 3,4-dihydroxyphenylalanine in plasma samples containing ethylenediaminetetraacetic acid.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Blood Specimen Collection; Carbidopa; Chelating Agents; Dihydroxyphenylalanine; Dopamine Agents; Edetic Acid; Humans; Levodopa; Temperature | 1995 |
Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.
Topics: Administration, Oral; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Injections, Intraperitoneal; Injections, Intravenous; Intubation, Gastrointestinal; Macaca fascicularis; Premedication; Time Factors; Tomography, Emission-Computed | 1995 |
Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression.
Topics: Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Depression; Desipramine; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Levodopa; Male; Motor Activity; Nitriles; Nitrophenols; Rats; Rats, Wistar; Swimming; Tolcapone | 1995 |
Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa.
Topics: Animals; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cerebellum; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Male; Nitriles; Rats; Rats, Wistar | 1994 |
Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study.
Topics: Animals; Brain; Carbidopa; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Drug Combinations; Drug Stability; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Injections, Intraventricular; Male; Oxidopamine; Pargyline; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1993 |
Evaluation of the ratio method compared with graphical analyses for estimating nigrostriatal function in human 18F-dopa PET studies with or without carbidopa.
Topics: Adult; Carbidopa; Corpus Striatum; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Reference Values; Substantia Nigra; Tomography, Emission-Computed | 1993 |
Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
Topics: Adult; Arteries; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Parkinson Disease; Reference Values; Tomography, Emission-Computed | 1993 |
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tyrosine | 1993 |
Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
Topics: Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Extracellular Space; Male; Nitriles; Nitrophenols; Rats; Rats, Sprague-Dawley; Tolcapone; Tyrosine | 1993 |
Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
Topics: Animals; Benzophenones; Biotransformation; Brain; Carbidopa; Catechol O-Methyltransferase Inhibitors; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enzyme Inhibitors; Fluorine Radioisotopes; Injections, Intravenous; Mice; Nitrophenols; Prodrugs; Time Factors; Tissue Distribution; Tolcapone; Tomography, Emission-Computed | 1996 |
The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
Topics: Animals; Carbidopa; Carbon Isotopes; Carrier Proteins; Cerebellum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Huntington Disease; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed | 1996 |
Flow injection spectrophotometric determination of L-Dopa and carbidopa in pharmaceutical formulations using a crude extract of sweet potato root [Ipomoea batatas (L.) Lam.] as enzymatic source.
Topics: Carbidopa; Dihydroxyphenylalanine; Levodopa; Spectrophotometry; Technology, Pharmaceutical; Vegetables | 1997 |
In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.
Topics: Animals; Apomorphine; Brain; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Flupenthixol; Kinetics; Male; Rats; Rats, Wistar; Receptors, Dopamine | 1997 |
Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Enzyme Inhibitors; Fluorine Radioisotopes; Humans; Premedication; Radiation Dosage; Radiation Protection; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder | 1998 |
Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
Topics: Aging; Animals; Animals, Newborn; Aromatic Amino Acid Decarboxylase Inhibitors; Blood-Brain Barrier; Brain; Carbidopa; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Kinetics; Macaca fascicularis; Metabolic Clearance Rate; Models, Neurological; Rats; Swine; Tomography, Emission-Computed | 1999 |
Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Drug Combinations; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine D2; Tomography, Emission-Computed | 1999 |
Enantioseparation of 3,4-dihydroxyphenylalanine and 2-hydrazino-2-methyl-3-(3,4-dihydroxyphenyl)propanoic acid by capillary electrophoresis using cyclodextrins.
Topics: Carbidopa; Cyclodextrins; Dihydroxyphenylalanine; Electrophoresis, Capillary; Stereoisomerism | 2000 |
Enantiomeric separation of dihydroxyphenylalanine (DOPA), methyldihydroxyphenylalanine (MDOPA) and hydrazinomethyldihydroxyphenylalanine (CDOPA) by using capillary electrophoresis with sulfobutyl ether-beta-cyclodextrin as a chiral selector.
Topics: beta-Cyclodextrins; Carbidopa; Cyclodextrins; Dihydroxyphenylalanine; Electrophoresis, Capillary; Indicators and Reagents; Methyldopa; Stereoisomerism | 2000 |
Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum.
Topics: Animals; Carbidopa; Chromatography, High Pressure Liquid; Denervation; Dihydroxyphenylalanine; Dopamine; Female; Gentisates; Hydroxybenzoates; Hydroxyl Radical; Neostriatum; Pregnancy; Rats; Salicylic Acid; Serotonin | 2000 |
Simultaneous determination of dopa and carbidopa enantiomers by capillary zone electrophoresis.
Topics: Carbidopa; Cyclodextrins; Dihydroxyphenylalanine; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2002 |
D-dopa is unidirectionally converted to L-dopa by D-amino acid oxidase, followed by dopa transaminase.
Topics: Animals; Carbidopa; D-Amino-Acid Oxidase; Dihydroxyphenylalanine; Enzyme Inhibitors; Kidney; Levodopa; Mice; Rats; Rats, Sprague-Dawley; Sodium Benzoate | 2006 |
Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography.
Topics: Carbidopa; Diagnostic Errors; Dihydroxyphenylalanine; Enzyme Inhibitors; Fluorine Radioisotopes; Humans; Hyperplasia; Insulin-Secreting Cells; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Premedication; Radiopharmaceuticals | 2008 |
Oxidation of carbidopa by tyrosinase and its effect on murine melanoma.
Topics: Animals; Antineoplastic Agents; Carbidopa; Cell Line, Tumor; Cyclization; Dihydroxyphenylalanine; Melanoma; Mice; Monophenol Monooxygenase; Oxidation-Reduction; Prodrugs | 2009 |
Peripheral COMT inhibition prevents levodopa associated homocysteine increase.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Delayed-Action Preparations; Dihydroxyphenylalanine; Enzyme Inhibitors; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Time Factors; Tyrosine | 2009 |
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease.
Topics: Aged; Aging; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychomotor Performance; Radiopharmaceuticals; Reaction Time; Retrospective Studies; Sex Characteristics; Tongue | 2011 |
Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antiparkinson Agents; Carbidopa; Catechin; Catechol O-Methyltransferase; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Disease Models, Animal; Excitatory Amino Acid Agonists; Fluoresceins; Glial Fibrillary Acidic Protein; Hippocampus; Hydroxybenzoates; In Vitro Techniques; Kainic Acid; Levodopa; Male; Methylation; Mice; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Reserpine; Time Factors; Tyrosine | 2013 |
Solid pseudopapillary pancreatic tumor mimicking a neuroendocrine neoplasm on ¹⁸F-FDOPA PET/CT.
Topics: Adult; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agents; Fluorine Radioisotopes; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
18F-FDOPA PET/CT imaging of insulinoma revisited.
Topics: Adult; Aged; Aged, 80 and over; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Insulinoma; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hyperinsulinism; Hypoglycemia; Insulinoma; Male; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Simultaneous determination of levodopa, carbidopa, entacapone, tolcapone, 3-O-methyldopa and dopamine in human plasma by an HPLC-MS/MS method.
Topics: Benzophenones; Blood Chemical Analysis; Carbidopa; Catechols; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Humans; Levodopa; Nitriles; Nitrophenols; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry; Tolcapone; Tyrosine | 2015 |
Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Topics: Animals; Brain; Carbidopa; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Presynaptic; Tyrosine | 2016 |
Simultaneous estimation of levodopa, carbidopa and 3-oxymethyldopa in rat plasma using HPLC-ECD.
Topics: Animals; Carbidopa; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Electrochemical Techniques; Levodopa; Limit of Detection; Male; Rats; Rats, Wistar; Tyrosine | 2016 |
Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Topics: Animals; Carbidopa; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Image Enhancement; Insulinoma; Metabolic Clearance Rate; Mice, Nude; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2017 |
Pancreatic Uptake by 18F-FDOPA PET/CT in Patients With Hypoglycemia After Gastric Bypass Surgery Compared With Controls With or Without Carbidopa Pretreatment.
Topics: Adult; Aged; Carbidopa; Case-Control Studies; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotopes; Gastric Bypass; Humans; Hypoglycemia; Male; Middle Aged; Pancreas; Pancreatic Diseases; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Premedication; Radiopharmaceuticals; Retrospective Studies | 2017 |
Clinical Value of
Topics: Adult; Aged; Aged, 80 and over; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Insulinoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Premedication; Radiopharmaceuticals; Retrospective Studies | 2018 |